To integrate this hypothesis, p53 inhibits ERα transcriptional activity on synthetic estrogen-responsive elements (40), suggesting a tumor-suppressive function of p53 towards ERα in hormone-activated signaling pathways. The gene discussed is TP53; the disease is neoplasm.